3QKM

Spirocyclic sulfonamides as AKT inhibitors

Summary for 3QKM

• Entry DOI: 10.2210/pdb3qkm/pdb
• Related: 3OCB
• Descriptor: RAC-alpha serine/threonine-protein kinase, N-(2-ethoxyethyl)-N-{(2S)-2-hydroxy-3-[(5R)-2-(quinazolin-4-yl)-2,7-diazaspiro[4.5]dec-7-yl]propyl}-2,6-dimethylbenzenesulfonamide (3 entities in total)
• Functional Keywords: kinase domain, transferase, transferase-transferase inhibitor complex, transferase/transferase inhibitor
• Biological source: Homo sapiens (human)
• Cellular location: Cytoplasm: P31749
• Total number of polymer chains: 1
• Total formula weight: 40048.74

Authors

Xu, R.,Banka, A.,Blake, J.F.,Mitchell, I.S.,Wallace, E.M.,Gloor, S.L.,Martinson, M.,Risom, T.,Gross, S.D.,Morales, T.,Vigers, G.P.A.,Brandhuber, B.J.,Skelton, N.J. (deposition date: 2011-02-01, release date: 2011-04-06, Last modification date: 2011-07-13)

• Primary citation: Xu, R.,Banka, A.,Blake, J.F.,Mitchell, I.S.,Wallace, E.M.,Bencsik, J.R.,Kallan, N.C.,Spencer, K.L.,Gloor, S.L.,Martinson, M.,Risom, T.,Gross, S.D.,Morales, T.H.,Wu, W.I.,Vigers, G.P.,Brandhuber, B.J.,Skelton, N.J.; Discovery of spirocyclic sulfonamides as potent Akt inhibitors with exquisite selectivity against PKA.; Bioorg.Med.Chem.Lett., 21:2335-2340, 2011; PubMed: 21420856; DOI: 10.1016/j.bmcl.2011.02.098

Experimental method

X-RAY DIFFRACTION (2.2 Å)